08-31-2023
INR/share | |
Price | 3,592.10 |
Dividend | 30.17 |
Earnings | 68.81 |
Cash-flow | 100.34 |
Book value | 478.95 |
Equity | 461.81 |
Divis Laboratories is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Divis Laboratories is a company from India, and his stocks are publicly traded.
Divis Laboratories stock dividend
Divis Laboratories paid a total dividend of 8,025 million INR last year, for a market value of 955,499 millions (Market Cap 457,739 millions). Divis Laboratories dividend per share is 30.17 INR, and his stock market price 3,592.10 INR.
According to the chart below, where dividend yield is displayed, Divis Laboratories has a dividend yield of 0.84%, lower than the amount offered by both the market average and companies from India. It is also lower than average of Health Care industry. This low dividend yield might has several explanations: company overpriced, expanding their business,...
In addition, you should compare Divis Laboratories stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the high India dividend stocks list.
Divis Laboratories Dividend Payout
About the ability of Divis Laboratories to maintain his current dividend of INR 30.17 per share, an amount that accounts for 0.84%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Divis Laboratories payout on ernings is currently 43.85%, which is higher than the market average, and companies of Health Care industry, which are 39.34% and 23.54% respectively. Both figures show that Divis Laboratories can have problems to keep with his present dividend yield.
The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Divis Laboratories is INR 100.34 per share, which is higher than the dividend per share paid by the company of INR 30.17, so the company generates enough cash to maintain his dividend in the future.
The following figure shows payout ratios over earnings and cashflow of Divis Laboratories, compared againt world market average, India companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.
Divis Laboratories Dividend History
Below you will find a table with the historical evolution of Divis Laboratories's dividend stock, both in percentage and in INR, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).
Year | Yield | INR | Paypout | Shares* |
Present | 0.84% | 30.17 | 43.85% | 266 |
2022 | 0.88% | 30.04 | 26.93% | 266 |
2021 | 0.43% | 20.12 | 26.88% | 266 |
2020 | 0.83% | 31.89 | 61.34% | 266 |
2019 | 0.87% | 16.06 | 31.50% | 266 |
2018 | 0.67% | 9.93 | 30.01% | 266 |
2017 | 0.91% | 9.99 | 24.92% | 266 |
2016 | 0.85% | 9.98 | 23.80% | 266 |
2015 | 0.87% | 10.01 | 31.24% | 266 |
*In millions
Then you can see the evolution of Divis Laboratories dividend stock, and compare it with the average of India stocks and that of the Pharmaceuticals and Biotechnology stocks.
Divis Laboratories Stock performance
Finally, last moth Divis Laboratories showed a return of -2.50% compared to a worldwide -2.49% average, and a -2.07% of Health Care firms. Over the last year, the company obtained a -1.00% versus a worldwide performance of a 8.71%. More detailed information can be seen in the following graph for India and Pharmaceuticals and Biotechnology firms.